ATE356208T1 - Regulation des menschliches lipoxin a4 rezeptor- ähnliches protein - Google Patents

Regulation des menschliches lipoxin a4 rezeptor- ähnliches protein

Info

Publication number
ATE356208T1
ATE356208T1 AT01925421T AT01925421T ATE356208T1 AT E356208 T1 ATE356208 T1 AT E356208T1 AT 01925421 T AT01925421 T AT 01925421T AT 01925421 T AT01925421 T AT 01925421T AT E356208 T1 ATE356208 T1 AT E356208T1
Authority
AT
Austria
Prior art keywords
receptor
protein
regulation
lipoxin
human lipoxin
Prior art date
Application number
AT01925421T
Other languages
English (en)
Inventor
Shyam Ramakrishnan
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Application granted granted Critical
Publication of ATE356208T1 publication Critical patent/ATE356208T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/88Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/10Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT01925421T 2000-03-14 2001-03-12 Regulation des menschliches lipoxin a4 rezeptor- ähnliches protein ATE356208T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18903700P 2000-03-14 2000-03-14

Publications (1)

Publication Number Publication Date
ATE356208T1 true ATE356208T1 (de) 2007-03-15

Family

ID=22695650

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01925421T ATE356208T1 (de) 2000-03-14 2001-03-12 Regulation des menschliches lipoxin a4 rezeptor- ähnliches protein

Country Status (7)

Country Link
US (1) US20020058259A1 (de)
EP (1) EP1266005B1 (de)
AT (1) ATE356208T1 (de)
AU (1) AU2001252181A1 (de)
DE (1) DE60127102T2 (de)
ES (1) ES2283403T3 (de)
WO (1) WO2001068839A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001036473A2 (en) * 1999-11-16 2001-05-25 Pharmacia & Upjohn Company Human g protein-coupled receptors
US20040038862A1 (en) * 2001-07-30 2004-02-26 Goodwin Bryan James Identification of new therapeutic targets for modulating bile acid synthesis
GB0119928D0 (en) * 2001-08-15 2001-10-10 Pfizer Ltd New use
US20060057577A1 (en) * 2002-03-22 2006-03-16 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with homo sapiens formyl peptide receptor-like 2
WO2003082314A2 (en) * 2002-04-03 2003-10-09 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1)
EP1504268A2 (de) * 2002-05-02 2005-02-09 Bayer HealthCare AG Diagnostika und therapeutika für krankheiten, die mit dem oxytocin rezeptor (oxtr) assoziiert sind
US10154977B2 (en) * 2011-03-25 2018-12-18 The Brigham And Women's Hospital, Inc. Anti-inflammatory particles
EP2597160B1 (de) 2011-11-23 2015-09-23 Universita' Degli Studi "G. d'Annunzio" Chieti-Pescara Untersuchungsinstrument für die Entdeckung von entzündungshemmenden Arzneimitteln mit einem FPR2/ALX-Gen-Promoter

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010080882A (ko) * 1998-10-13 2001-08-25 리처드 피. 버군 쥬니어 구성적으로 활성화된 비내생성 인간 g 단백질 결합형수용체
EP1155031A4 (de) * 1998-11-03 2002-11-27 Smithkline Beecham Corp Axor14, ein g-protein gekoppelter rezeptor
DK1584683T3 (da) * 1998-11-20 2007-10-29 Arena Pharm Inc Human G-protein-koblet orphan receptor RUP3
DE19930512A1 (de) * 1999-07-05 2001-01-11 Michael Brues NFORMYL: gen, cDNA, Expression und Aminosäuresequenz
GB9924960D0 (en) * 1999-10-21 1999-12-22 Pfizer Ltd Novel polypeptide
WO2001036473A2 (en) * 1999-11-16 2001-05-25 Pharmacia & Upjohn Company Human g protein-coupled receptors
AU1956701A (en) * 1999-12-10 2001-06-18 Incyte Genomics, Inc. G-protein coupled receptors

Also Published As

Publication number Publication date
WO2001068839A2 (en) 2001-09-20
EP1266005A2 (de) 2002-12-18
DE60127102T2 (de) 2007-08-23
WO2001068839A3 (en) 2002-03-28
ES2283403T3 (es) 2007-11-01
EP1266005B1 (de) 2007-03-07
DE60127102D1 (de) 2007-04-19
AU2001252181A1 (en) 2001-09-24
WO2001068839A9 (en) 2002-07-18
US20020058259A1 (en) 2002-05-16

Similar Documents

Publication Publication Date Title
EA200701036A1 (ru) Лактамные соединения и их применение в качестве фармацевтических препаратов
DE60322339D1 (de) Bindungsproteine als biosensoren
WO2004035747A3 (en) Human anti-ifn-ϝ neutralizing antibodies as selective ifn-ϝ pathway inhibitors
EA030259B8 (ru) Человеческие нейтрализующие антитела к фактору роста нервов (ngf) в качестве селективных ингибиторов метаболического пути ngf
EA200700118A1 (ru) Амидосоединения и их применение в качестве лекарственных средств
NO20043245L (no) Bindingsproteiner som biosensorer
ATE497783T1 (de) Gerinnungsfaktor vii-fc chimäre proteine zur behandlung von hämostatischen krankheiten
NZ592973A (en) Compositions and methods of using angiopoietin-like 4 protein
NZ594514A (en) Interleukin-17 BINDING PROTEINS
BR0011838A (pt) Elementos misturadores estáticos empilhados
WO2003002114A3 (en) Use of potent, selective and non toxic c-kit inhibitors for treating mastocytosis
WO2004039956A3 (en) Compositions and methods for the treatment of immune related diseases
EA200401471A1 (ru) Применение ингибиторов сетр и возможных ингибиторов hmg coa и/или антигипертензивных агентов
BG66080B1 (bg) Заместени тиоацетамиди
AU2000233235A1 (en) Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase
ATE356208T1 (de) Regulation des menschliches lipoxin a4 rezeptor- ähnliches protein
DE60313434D1 (de) Verfahren und zusammensetzungen zur behandlung von hyperproliferativen zuständen
DE60216281D1 (de) Die verwendung von tyrosinkinasehemmer zur behandlung von allergischen erkrankungen
WO2003002108A3 (en) Use of tyrosine kinase inhibitors for treating inflammatory diseases
BRPI0514124B8 (pt) anticorpos monoclonais específicos para il-4 humana, seu uso, composição farmacêutica que os comprende e polinucleotídeos
WO2004024072A3 (en) Novel compositions and methods for the treatment of immune related diseases
WO2001042431A3 (en) Regulation of human mitochondrial deformylase
ATE320255T1 (de) Tie2 rezeptor-kinase-inhibitoren zur behandlung von angiogenen erkrankungen
ATE305041T1 (de) Kompositionen und verwendungen von cgi-69
WO2003000858A3 (en) Pharmacological targeting of bacterial dna ligase for treatment and prevention of bacterial infections

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties